Predictors of mortality in adult patients with congestive heart failure receiving nesiritide - Retrospective analysis showing a potential adverse interaction between neseritide and acute renal dysfunction

Nephrology Dialysis Transplantation

Volumn 23, Issue 1, 2008, Pages 144-153

  Iglesias, Jose I ^a,b,c,f   DePalma, Laura ^d   Hom, Deborah ^c   Antoniotti, Maria ^c   Ayoub, Sammy ^c   Levine, Jerrold S ^e  

^a UMDNJ School of Osteopathic Medicine   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Department of Medicine Rutgers Health Community Medical Center Internal Medicine Residency Program   (United States)

^d PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^e UNIVERSITY OF ILLINOIS   (United States)

^f NONE   (United States)

Author keywords

Acute renal failure; Brain natriuretic peptide; Congestive heart failure; Nesiritide

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; NESIRITIDE; NITRATE; BRAIN NATRIURETIC PEPTIDE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BOLUS INJECTION; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DRUG USE; FEMALE; GERIATRIC PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; CHEMICALLY INDUCED DISORDER; HEART FAILURE;

AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; NATRIURETIC PEPTIDE, BRAIN; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 44449152577     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm565     Document Type: Article

References (16)

1. Abraham WT, Lowes BD, Ferguson DA et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Cardiac Fail 1998; 4: 37-44
2. Colucci WS, Elkayam U, Horton DP et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J of Med 2000; 343: 246-253
3. Sackner-Bernstein JD, Kowalski M, Fox M et al. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005; 293: 1900-1905
4. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005; 111: 1487-1491
5. Iglesias J, Hom D, Antoniotti M et al. Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide). Nephrol Dial Transplant 2006; 21: 3458-3465
6. Centers for Medicare and Medicaid Services National Heart Failure Quality Improvement Project. United States Department Health and Human Services: 2001; 1-13.
7. US Health Care Financing Administration. Diagnosis-related Groups Definitions Manual. 3M Health Information Services, Wallingford CT: 1993
8. Butler J, Forman DE, Abraham WT et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004; 147: 331-338
9. Pitt B, Segal R, Martinez FA et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997; 349: 747-752
10. Rule AD, Larson TS, Bergstralh EJ et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 929-930
11. Fonarow GC, Corday E. Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry. Heart Fail Rev 2004; 9: 179-185
12. Forman DE, Butler J, Wang Y et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004; 43: 61-67
13. Gottdiener JS, McClelland RL, Marshall R et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann of Intern Med 2002; 137: 631-639
14. Gottlieb SS, Abraham W, Butler J et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002; 8: 136-141
15. Heywood JT. The cardiorenal syndrome: lessons from the ADHERE database and treatment options. Heart Fail Rev 2004; 9: 195-201
16. Kittleson M, Hurwitz S, Shah MR et al. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol 2003; 41: 2029-2035